Is Aura Biosciences, Inc. (AURA) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 5.3% / 30% | 42.5% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 5.3% / 33% | 42.5% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 10.3% / 33% | 82.8% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 5.3% / 33% | 42.5% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 10.3% / 33% | 82.8% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -64.3% | |
| Return on Assets (ROA) | -35.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$80M |
| Free Cash Flow | -$81M |
| Total Debt | $19M |
| Debt-to-Equity | 11.3 |
| Current Ratio | 9.0 |
| Total Assets | $183M |
Price & Trading
| Last Close | $6.44 |
| 50-Day MA | $5.81 |
| 200-Day MA | $6.09 |
| Avg Volume | 226K |
| Beta | 0.4 |
|
52-Week Range
$4.34
| |
About Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Aura Biosciences, Inc. (AURA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Aura Biosciences, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Aura Biosciences, Inc.'s debt ratio?
Aura Biosciences, Inc.'s debt ratio is 5.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 10.3%.
What are Aura Biosciences, Inc.'s key financial metrics?
Aura Biosciences, Inc. has a market capitalization of $398M. Return on equity stands at -64.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.